Turnstone Biologics Corp. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Turnstone Biologics Corp. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2024.
  • Turnstone Biologics Corp. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.39M, a 56.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.39M -$1.83M -56.7% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.85M -$1.85M -49.9% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $2.31M Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $2.77M -$1.87M -40.3% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $3.22M Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.7M Jun 30, 2023 10-Q 2023-09-01
Q4 2022 $4.63M Dec 31, 2022 10-K 2024-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.